Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-182-8 | CAS number: 134652-60-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 15 July to 3 August 2009
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Recent study conducted by a GLP certified laboratory in accordance with a suitable study guideline.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 009
- Report date:
- 2009
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- Tripropan-2-ylsilyl 2-methylprop-2-enoate
- EC Number:
- 700-182-8
- Cas Number:
- 134652-60-1
- Molecular formula:
- C13 H26 O2 Si
- IUPAC Name:
- Tripropan-2-ylsilyl 2-methylprop-2-enoate
- Details on test material:
- - Name of test material (as cited in study report): TIS-M
- Lot/batch No.: 8211
- Expiration date of the lot/batch: 12 June 2010
- Storage condition of test material: Under nitrogen at room temperature, protected from light.
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Charles River France, L'Arbresle Cedex, France.
- Age at study initiation: approx. 12 weeks old.
- Weight at study initiation: Body weight variation within +/- 20% of the sex mean.
- Housing: Animals were individually housed in Macrolon cages (MI type, height: 12.5cm). Sterilised sawdust was used as bedding material (Litalobo, S.P.P.S, Argenteui, France) and paper was supplied as cage-enrichment (Enviro-dri, Wm. Lillico and Son (Wonham Mill Ltd.), Surrey, United Kingdom). The paper was removed on day 1 prior to dosing and was supplied again after scoring of the ears on day 3.
- Diet: SM R/M-Z from SSNIF® Spezialdiäten GmbH, Soest, Germany; ad libitum
- Water: Tap water; ad libitum.
- Acclimation period: At least 5 days before treatment. Accomodation was the same but the Macrolon cages were MIII type, height 18cm.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21.5-23.5°C
- Humidity (%): 40-70% (actual range 41-76%). Cleaning procedures in the room might have caused temporary fluctuations above the optimal maximumof 70% for relative humidity. Based on laboratory historical data, these fluctuations were considered not to have affected the study integrity.
- Air changes (per hr): approx. 15
- Photoperiod: 12 hours light, 12 hours dark.
IN-LIFE DATES: From: 15 July To: 3 August 2009
Study design: in vivo (LLNA)
- Vehicle:
- methyl ethyl ketone
- Concentration:
- 0% (vehicle only), 25%, 50% and 100% concentrations.
- No. of animals per dose:
- 5
- Details on study design:
- Preliminary irritation study
A preliminary irritation study was conducted in order to select the highest test substance concentration to be used in the main study. In principle, this concentration should be well tolerated systemically by the animals and may give moderate irritation (maximally grade 2) at theh ighest concentration.
Two test substance concentrations were tested; a 100% and 50% concentration. The highest concentration was the maximum concentration as required in the test guidelines (undiluted for liquids).
The test system, procedures and techniques were identical to those used during Days 1 to 3 of the main study unless otherwise specified. Two young adult animals were selected (8-14 weeks old). Each animal was treated with one concentration on three consecutive days. Approximately 3-4 hours after the last exposure, the irritation of the ears was assessed. Bodyweights were determined on Day 3. The animals were sacrificed after the final observation and no necropsy was performed.
Main study
Three groups of five animals were treated with one test substance concentration per group. The highest test substance concentration was selected from the preliminary irritation study. One group of five animals was treated with vehicle.
Induction - Days 1, 2 and 3
The dorsal surface of both ears was epidermally treated (25 uL/ear) with the test substance concentration, at approximately the same time per day. The concentrations were mixed thoroughly using a vortex mixer immediately prior to dosing.
The control animals were treated the same as the experimental animals, except that, instead of the test substance, the vehicle alone was administered.
Excision of the nodes - Day 6
All animals:
Each animal was injected via the tail vein with 0.25 ml_ of sterile phosphate buffered saline (PBS) (Merck, Darmstadt, Germany) containing 20 uCi of 3H-methyl thymidine (GE Health care, Buckinghamshire, UK).
After approximately five hours, all animals were killed by intraperitoneal injection with Euthasol® 20% (AST Farma BV, Oudewater, The Netherlands). The draining (auricular) lymph node of each ear was excised.
The relative size of the nodes (as compared to normal) was estimated by visual examination and abnormalities of the nodes and surrounding areawere recorded. The nodes were pooled for each animal in approximately 3 ml_ PBS.
Tissue processing for radioactivity - Day 6
A single cell suspension of lymph node cells (LNC) was prepared in PBS by gentle separation through stainless steel gauze (diameter 125 urn). LNC were washed twice with an excess of PBS by centrifugation at 200g for 10 minutes at 4°C. To precipitate the DNA, the LNC were exposed to 5% trichloroacetic acid (TCA) (Merck, Darmstadt, Germany) stored in the refrigerator until the next day.
Radioactivity measurements - Day 7
Precipitates were recovered by centrifugation, resuspended in 1 mL TCA and transferred to 10 mL of Ultima Gold cocktail (PerkinElmer Life and Analytical Sciences, Boston, MA, US) as the scintillation fluid. Radioactive measurements were performed using a Packard scintillation counter (2800TR). Counting time was to a statistical precision of ± 0.2% or a maximum of 5 minutes whichever came first. The scintillation counter was programmed to automatically subtract background and convert Counts Per Minute (CPM) to Disintegrations Per Minute (DPM).
Observations
Mortality /Viability Twice daily.
Toxicity At least once daily.
Body weights On Days 1 (pre-treatment) and 6.
Irritation On Day 3 (3-4 hours after treatment), the skin reactions were assessed. Skin reactions were graded according to the following numerical scoring system. Furthermore descriptions of all other (local) effects were recorded. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
Results and discussion
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Remarks on result:
- other: see Remark
- Remarks:
- The Stimulation Index (SI) is the ratio of the DPM/group compared to the DPM/vehicle group. If the results indicate a SI ≥ 3, the substance may be regarded as a skin sensitiser. Consideration was also given to the EC3 value (the estimated test substance concentration that will give SI = 3. The SI values calculated for the substance concentrations 25. 50 and 100% were 18.7, 40.8 and 35.7 respectively. These results inidcate that the test substance could elict a SI ≥ 3. The response of the 100% group did not follow the expected dose-response relationship which is more often seen in these kind of studies. The response might be less due to differences in skin penetration (no vehicle present) or viscosity or due to underlying systematic toxicity. No reliable EC3 value could be calculated. As the SI values clearly exceeded 3, TIS-M was determined to be a skin sensitiser.
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: DPM values are presented for each animal and each dose group below.
Any other information on results incl. tables
Table 1: Skin reactions after epidermal exposure and body weights (Preliminary Study):
Animal number |
Test Substance (% w/w) |
Day 1 |
Day 3 |
||||
Body Weight (g) |
Skin reactions dorsal surface ear |
Body weight (g) |
|||||
Left |
Right |
||||||
erythema |
oedema |
erythema |
oedema |
||||
1 |
50 |
26 |
1 |
0 |
1 |
0 |
24 |
2 |
100 |
23 |
1 |
0 |
1 |
0 |
20 |
- Vehicle: Methyl ethyl ketone
Table 2: Skin reactions, body weights and relative size auricular lymph nodes (Main Study):
Group |
Test Substance (% w/w) |
Animal Number |
Day 1 |
Day 3 |
Day 6 |
|||||
Body Weight (g) |
Skin reactions dorsal surface ear |
Body Weight (g) |
Size nodes |
|||||||
Left |
Right |
|||||||||
erythema |
oedema |
erythema |
oedema |
left |
right |
|||||
1 |
0% (vehicle) |
1 |
25 |
0 |
0 |
0 |
0 |
24 |
n |
n |
2 |
24 |
0 |
0 |
0 |
0 |
23 |
n |
n |
||
3 |
22 |
0 |
0 |
0 |
0 |
23 |
n |
n |
||
4 |
24 |
0 |
0 |
0 |
0 |
24 |
n |
n |
||
5 |
23 |
0 |
0 |
0 |
0 |
23 |
n |
n |
||
2 |
25% |
6 |
26 |
1 |
0 |
1 |
0 |
24 |
+ |
n |
7 |
23 |
1 |
0 |
1 |
0 |
23 |
n |
+ |
||
8 |
25 |
1 |
0 |
1 |
0 |
25 |
n |
n |
||
9 |
24 |
1 |
0 |
1 |
0 |
24 |
+ |
+ |
||
10 |
22 |
1 |
0 |
1 |
0 |
22 |
n |
n |
||
3 |
50% |
11 |
23 |
1 |
0 |
1 |
0 |
22 |
++ |
++ |
12 |
25 |
1 |
0 |
1 |
0 |
23 |
++ |
++ |
||
13 |
23 |
1 |
0 |
1 |
0 |
23 |
+ |
+ |
||
14 |
25 |
1 |
0 |
1 |
0 |
23 |
++ |
++ |
||
15 |
22 |
1 |
0 |
1 |
0 |
21 |
+ |
+ |
||
4 |
100% |
16 |
23 |
1 |
0 |
1 |
0 |
22 |
+ |
+ |
17 |
25 |
1 |
0 |
1 |
0 |
24 |
++ |
++ |
||
18 |
22 |
1 |
0 |
1 |
0 |
21 |
+ |
+ |
||
19 |
25 |
1 |
0 |
1 |
0 |
24 |
+ |
+ |
||
20 |
26 |
1 |
0 |
1 |
0 |
25 |
++ |
++ |
- Vehicle: Methyl ethyl ketone
- Relative size auricular lymph nodes (-, -- or ---: degree of reduction; +, ++ or +++: degree of enlargement, n considered to be normal.
Table 3: Radioactivity measurements (individual animals):
Group |
Test substance (% w/w) |
Animal number |
DPM/animal |
1 |
0% (vehicle) |
1 |
158 |
2 |
211 |
||
3 |
136 |
||
4 |
147 |
||
5 |
254 |
||
2 |
25% |
6 |
3720 |
7 |
2710 |
||
8 |
4638 |
||
9 |
5786 |
||
10 |
117 |
||
3 |
50% |
11 |
5484 |
12 |
9622 |
||
13 |
5787 |
||
14 |
7816 |
||
15 |
8292 |
||
4 |
100% |
16 |
4496 |
17 |
7225 |
||
18 |
29* |
||
19 |
9698 |
||
20 |
4479 |
- Vehicle: Methyl ethyl ketone
- * = value rejected (activity too low to represent an acceptable level of activity for this study).
Table 4: Disintegrations Per Minute (DPM) and Stimulation Index (SI):
Group |
Test substance (% w/w) |
Mean DPM± SEM |
SI±SEM |
2 |
25% |
3394±964 |
18.7±5.8 |
3 |
50% |
7400±780 |
40.8±6.6 |
4 |
100% |
6475±1253 |
35.7±8.2 |
1 |
0% (vehicle) |
181±22 |
1.0 ± 0.2 |
- Vehicle: Methyl ethyl ketone
Preliminary irritation study: (Table 1):
The concentration selected for the main study was the highest concentration: 100% concentration.
Main study: Skin reactions/irritation: (Table 2):
The slight irritation of the ears as shown by all experimental animals was considered not to have a toxicologically significant effect on the activity of the nodes.
Main study: Macroscopy of the auricular lymph nodes and surrounding area: (Table 2):
The majority of the auricular lymph nodes were condsidered to be enlarged. No macroscopic abnormalities of the surrounding area were noted.
Main study: Body weights: (Table 2):
Body weights and body weight gain of experimental animals remained in the same range as controls over the study period. The slight body weight loss, noted in some animals, was considered not to be toxicologically significant.
Main study: Radioactivity measurements (Tables 3 and 4):
Mean DPM/animal values for the experimental groups treated with test substance concentrations 25, 50 and 100% were 3394, 7400 and 6475 respectively . The mean DPM/animal value for the vehicle control group was 181.
No mortality occured and no symptoms of systematic toxicity were observed in the animals of the main study.
Reliability check results: (Table and graphs in attached background material):
The SI values calculated for the susbtance concentrations 5, 10 and 25% were 2.0, 2.2 and 4.2 respectively. An EC3 value of 16.0% was calculated using linear interpolation.The calculated EC3 value was found to be in the acceptable range of 2 -20%. The results of the 6 monthly HCA reliability checks in recent years were 13.1, 15.6, 14.1, 13.8 and 13.9%. Based on the results, it was concluded that the Local Lymph Node Assay as performed by NOTOX is an appropriate model for testing for contact hypersensitivity.
Applicant's summary and conclusion
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information
- Conclusions:
- The registered substance was determined to be a skin sensitiser, as the SI values were all above 3.
- Executive summary:
A skin sensitivity study of the substance was carried out according to EU Method B.42 (Local Lymph Node Assay) using CBA mice.
The registered substance was applied to the dorsal surface of both ears and after 6 days the substance was determined to be a skin sensitiser.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.